Meeting report: The future of preclinical mouse models in melanoma treatment is now.
about
Current State of Animal (Mouse) Modeling in Melanoma ResearchModeling nasopharyngeal carcinoma in three dimensions"Glowing head" mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts.Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograftType I cytokines synergize with oncogene inhibition to induce tumor growth arrest.ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies.Modeling Melanoma In Vitro and In Vivo.Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?Melanoma patient derived xenografts acquire distinct Vemurafenib resistance mechanisms.Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance.
P2860
Q26781652-5070006A-F7A5-45F3-B4BC-51EB92405735Q33599243-003B12FB-0F0A-418E-B4F5-7AB167885BA2Q34450094-DE6764C7-56B9-4AA2-AB5C-3365D2527025Q34566212-B91BE2A0-CC47-4358-A77A-18767B97CD21Q34892977-94006AF9-DACE-48DA-A1B4-A75F7C7598DFQ36301027-80381E6C-078E-482B-9171-28D84838AE2AQ36759354-0FA3F8A8-D6BF-4B79-86BA-99C4ADC004F2Q37069214-81EEAE9B-A985-4728-9667-EDC1F4CDDE6CQ38592069-7E3438E5-C9D1-4E80-9D04-43A0F34BD10FQ41826057-41A94B9F-FAE6-4972-B84E-05593118FE96Q51098298-47C4FBAA-18BE-4DCF-AE82-2DD0F1E79267
P2860
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
@ast
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
@en
type
label
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
@ast
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
@en
prefLabel
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
@ast
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
@en
P2093
P356
P1476
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
@en
P2093
Andrew Aplin
Chi-Ping Day
Glenn Merlino
Nicolas Acquavella
Sheri Holmen
Suzanne Topalian
Terry Van Dyke
P304
P356
10.1111/PCMR.12099
P577
2013-04-08T00:00:00Z